ENANTA PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
ENANTA PHARMACEUTICALS, INC (ENTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $32.30 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $32.30.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $32.21.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $32.50.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $36.31.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $32.30 10-Q · filed 2026-08-12 |
| 2026-03-31 | $32.21 10-Q · filed 2026-05-13 |
| 2025-12-31 | $32.50 10-Q · filed 2026-02-11 |
| 2025-09-30 | $36.31 10-K · filed 2025-11-19 |
| 2025-06-30 | $36.02 10-Q · filed 2025-08-13 |
| 2025-03-31 | $36.13 10-Q · filed 2025-05-14 |
| 2024-12-31 | $36.69 10-Q · filed 2025-02-12 |
| 2024-09-30 | $42.67 10-K · filed 2024-11-27 |
| 2024-06-30 | $42.82 10-Q · filed 2024-08-07 |
| 2024-03-31 | $43.70 10-Q · filed 2024-05-08 |
| 2023-12-31 | $44.17 10-Q · filed 2024-02-08 |
| 2023-09-30 | $52.68 10-K · filed 2023-11-22 |
| 2023-06-30 | $52.74 10-Q · filed 2023-08-08 |
| 2023-03-31 | $52.98 10-Q · filed 2023-05-09 |
| 2022-12-31 | $52.59 10-Q · filed 2023-02-08 |
| 2022-09-30 | $53.57 10-K · filed 2022-11-23 |
| 2022-06-30 | $53.19 10-Q · filed 2022-08-08 |
| 2022-03-31 | $53.13 10-Q · filed 2022-05-09 |
| 2021-12-31 | $52.74 10-Q · filed 2022-02-10 |
| 2021-09-30 | $48.61 10-K · filed 2021-11-24 |
| 2021-06-30 | $48.75 10-Q · filed 2021-08-09 |
| 2021-03-31 | $48.77 10-Q · filed 2021-05-10 |
| 2020-12-31 | $48.69 10-Q · filed 2021-02-09 |
| 2020-09-30 | $49.82 10-K · filed 2020-11-25 |
| 2020-06-30 | $50.14 10-Q · filed 2020-08-10 |
| 2020-03-31 | $50.20 10-Q · filed 2020-05-11 |
| 2019-12-31 | $49.53 10-Q · filed 2020-02-10 |
| 2019-09-30 | $46.54 10-K · filed 2019-11-27 |
| 2019-06-30 | $46.22 10-Q · filed 2019-08-09 |
| 2019-03-31 | $45.17 10-Q · filed 2019-05-10 |
| 2018-12-31 | $43.67 10-Q · filed 2019-02-08 |
| 2018-09-30 | $36.65 10-K · filed 2018-11-29 |
| 2017-09-30 | $30.35 10-K · filed 2017-12-11 |
| 2017-06-30 | $30.08 10-Q · filed 2017-08-09 |
| 2017-03-31 | $29.54 10-Q · filed 2017-05-10 |
| 2016-12-31 | $29.72 10-Q · filed 2017-02-09 |
| 2016-09-30 | $29.65 10-K · filed 2016-12-09 |
| 2016-06-30 | $29.84 10-Q · filed 2016-08-09 |
| 2016-03-31 | $29.15 10-Q · filed 2016-05-10 |
| 2015-12-31 | $27.03 10-Q · filed 2016-02-09 |
| 2015-09-30 | $24.71 10-K · filed 2015-12-11 |
| 2015-06-30 | $24.22 10-Q · filed 2015-08-10 |
| 2015-03-31 | $23.26 10-Q · filed 2015-05-08 |
| 2014-12-31 | $21.32 10-Q · filed 2015-02-06 |
| 2014-09-30 | $15.47 10-K · filed 2014-12-11 |
| 2014-06-30 | $15.20 10-Q · filed 2014-08-12 |
| 2014-03-31 | $12.71 10-Q · filed 2014-05-12 |
| 2013-12-31 | $8.09 10-Q · filed 2014-02-13 |
| 2013-09-30 | $4.06 10-K · filed 2013-12-18 |
| 2013-06-30 | $3.76 10-Q · filed 2013-08-12 |
| 2013-03-31 | $4.77 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |